Source: Journal of Clinical Psychopharmacology. Unidades: FFCLRP, FMRP
Subjects: ANTIPSICÓTICOS, MÉTODO DUPLO-CEGO, FARMACOTERAPIA, ESQUIZOFRENIA, RESULTADO DE TRATAMENTO, FÁRMACOS (SISTEMA CARDIOVASCULAR)
ABNT
GUIMARÃES, Tiago Moraes et al. Mononitrate isosorbide as an adjunctive therapy in schizophrenia: a randomized controlled crossover trial. Journal of Clinical Psychopharmacology, v. 41, n. 3, p. 260-266, 2021Tradução . . Disponível em: https://doi.org/10.1097/JCP.0000000000001388. Acesso em: 17 nov. 2024.APA
Guimarães, T. M., Guimarães, M. R. C., Oliveira, Í. A. F., Leoni, R. F., Santos, A. C. dos, Dursun, S. M., et al. (2021). Mononitrate isosorbide as an adjunctive therapy in schizophrenia: a randomized controlled crossover trial. Journal of Clinical Psychopharmacology, 41( 3), 260-266. doi:10.1097/JCP.0000000000001388NLM
Guimarães TM, Guimarães MRC, Oliveira ÍAF, Leoni RF, Santos AC dos, Dursun SM, Crippa JA de S, Bressan RA, Machado-de-Sousa JP, Lacerda ALT, Hallak JEC. Mononitrate isosorbide as an adjunctive therapy in schizophrenia: a randomized controlled crossover trial [Internet]. Journal of Clinical Psychopharmacology. 2021 ; 41( 3): 260-266.[citado 2024 nov. 17 ] Available from: https://doi.org/10.1097/JCP.0000000000001388Vancouver
Guimarães TM, Guimarães MRC, Oliveira ÍAF, Leoni RF, Santos AC dos, Dursun SM, Crippa JA de S, Bressan RA, Machado-de-Sousa JP, Lacerda ALT, Hallak JEC. Mononitrate isosorbide as an adjunctive therapy in schizophrenia: a randomized controlled crossover trial [Internet]. Journal of Clinical Psychopharmacology. 2021 ; 41( 3): 260-266.[citado 2024 nov. 17 ] Available from: https://doi.org/10.1097/JCP.0000000000001388